MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 57 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,932,044 | +8.9% | 2,558,724 | +0.1% | 0.00% | +100.0% |
| Q2 2023 | $7,282,568 | -27.6% | 2,555,287 | +0.1% | 0.00% | -50.0% |
| Q1 2023 | $10,056,712 | -4.1% | 2,552,465 | -3.6% | 0.00% | 0.0% |
| Q4 2022 | $10,482,579 | +991.9% | 2,647,116 | +2433.2% | 0.00% | – |
| Q3 2022 | $960,000 | +1197.3% | 104,497 | +770.5% | 0.00% | – |
| Q2 2022 | $74,000 | -3.9% | 12,004 | 0.0% | 0.00% | – |
| Q1 2022 | $77,000 | -2.5% | 12,004 | 0.0% | 0.00% | – |
| Q4 2021 | $79,000 | +14.5% | 12,004 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | +4.5% | 12,004 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | -5.7% | 12,004 | 0.0% | 0.00% | – |
| Q1 2021 | $70,000 | -53.0% | 12,004 | -46.0% | 0.00% | – |
| Q4 2020 | $149,000 | +69.3% | 22,250 | +85.4% | 0.00% | – |
| Q3 2020 | $88,000 | – | 12,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
| Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
| ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
| RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
| Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
| Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
| VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
| Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
| Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
| Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |